Focus: Eko Devices develops FDA-cleared digital stethoscopes and AI-powered auscultation algorithms for cardiopulmonary and renal disease detection. Public-stage medical device company headquartered in Emeryville, CA with a focused hardware-software platform.
Profile data last refreshed 11h ago · AI intelligence enriched 1w ago
Stable — net +4 jobs in 30d
10 added, 6 removed. Backfill posture.
Career fit depends on device-hardware-AI specialization preference; not suitable for traditional pharma drug-development track, but strong for medtech innovation and digital health scale-up experience.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Eko Devices
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Eko Devices's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Deep Learning Algorithms to Detect Murmurs Associated With Structural Heart Disease.
Automated detection of low ejection fraction from a one-lead electrocardiogram: application of an AI algorithm to an electrocardiogram-enabled Digital Stethoscope().
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo